Maria Re to Viremia
This is a "connection" page, showing publications Maria Re has written about Viremia.
Connection Strength
0.050
-
Evaluation of HIV-DNA and inflammatory markers in HIV-infected individuals with different viral load patterns. BMC Infect Dis. 2017 08 22; 17(1):581.
Score: 0.025
-
Substitution of nevirapine or raltegravir for protease inhibitor vs. rosuvastatin treatment for the management of dyslipidaemia in HIV-infected patients on stable antiretroviral therapy (Nevrast study). Infect Dis (Lond). 2017 Oct; 49(10):737-747.
Score: 0.025